In the past 5 years, the field of oncolytic virus research has matured significantly and is moving past the stage of being a laboratory novelty into a new era of preclinical and clinical trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting new line of therapeutics?
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nrc1750 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!